60 Participants Needed

Medically Tailored Meals for Heart Failure

Recruiting at 1 trial location
RS
VM
Overseen ByValerie Mercer, MPH, MA
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of California, San Diego
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This study will look at the effects of providing medically tailored meals (MTMs) to people with heart disease for twelve weeks. The primary outcome of the study is the quality of the diet being consumed in week 12 of the study, as determined by the "Healthy Eating Index."

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently taking insulin or meglitinides.

What data supports the effectiveness of the treatment Medically Tailored Meals for Heart Failure?

Research shows that medically tailored meals can help improve health outcomes for patients with heart failure by providing necessary nutrition, which may reduce hospital readmissions and improve overall health. Additionally, similar approaches in other conditions, like lung cancer, have shown improvements in quality of life and reduced complications.12345

Are medically tailored meals safe for humans?

Medically tailored meals have been studied in various settings, including for patients with heart failure and type 2 diabetes, and are generally considered safe as they are designed to meet specific nutritional needs and are prescribed by healthcare providers.12678

How are medically tailored meals different from other treatments for heart failure?

Medically tailored meals are unique because they provide personalized nutrition support delivered to patients' homes, focusing on meeting specific dietary needs and addressing malnutrition, unlike other treatments that often emphasize dietary restrictions without personalization.29101112

Research Team

CA

Cheryl Anderson, PhD, MPH, MS

Principal Investigator

UC San Diego

CG

Christopher Gardner, PhD

Principal Investigator

Stanford University

Eligibility Criteria

This trial is for individuals with heart disease, specifically those diagnosed with heart failure or congestive heart failure. The details of the inclusion and exclusion criteria are not provided, but typically participants would need to meet certain health conditions.

Inclusion Criteria

Current diet can be improved
Willing to eat all meals provided by the study
Living in San Diego or the Bay Area of California
See 2 more

Exclusion Criteria

I have been diagnosed with advanced heart failure.
Current smoker or tobacco use within the past year
I have been diagnosed with type 1 diabetes or my type 2 diabetes is not under control.
See 8 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive medically tailored meals (MTMs) for 12 weeks

12 weeks
Weekly meal delivery

Follow-up

Participants are monitored for changes in diet quality and food security

12 weeks
In-person visits at Week 12 and Week 24

Treatment Details

Interventions

  • Medically Tailored Meals
Trial Overview The study is testing whether providing 14 or 15 medically tailored meals per week can improve the quality of diet in patients with heart failure over a period of twelve weeks, measured by the 'Healthy Eating Index'.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: 15 Medically Tailored Meals (MTM) + snacksExperimental Treatment1 Intervention
Participants will receive 15 medically tailored meals (MTM) per week, plus snacks, for 12 weeks.
Group II: 14 Medically Tailored Meals (MTM)Experimental Treatment1 Intervention
Participants will receive 14 medically tailored meals (MTM) per week for 12 weeks.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Diego

Lead Sponsor

Trials
1,215
Recruited
1,593,000+

Stanford University

Collaborator

Trials
2,527
Recruited
17,430,000+

Findings from Research

A study involving 650 patients with chronic conditions found that receiving medically tailored meals (MTM) for 2 weeks led to a significant reduction in anxiety and depression scores compared to baseline, while the 4-week group did not show similar improvements.
However, there were no significant differences in overall patient outcomes, such as activities of daily living, nutritional risk, or rates of emergency department visits and rehospitalizations, between the 2-week and 4-week MTM groups.
Comparing two durations of medically tailored meals posthospitalization: A randomized clinical trial.Boxer, R., Drace, ML., Kelly, C., et al.[2023]
The study evaluated the effects of home-delivered, medically tailored meals on food-insecure patients after hospitalization for congestive heart failure, involving 39 participants compared to a matched cohort of 117 patients.
While participants showed a slight reduction in body mass index and an increase in blood pressure, these changes were not statistically significant; however, there was a trend suggesting that the intervention may improve dietary habits and potentially reduce blood pressure over time.
The impact of medically tailored meals and nutrition therapy on biometric and dietary outcomes among food-insecure patients with congestive heart failure: a matched cohort study.Belak, L., Owens, C., Smith, M., et al.[2022]
In a study of 570 heart failure inpatients, the use of oral nutrition supplements (ONS) was linked to a higher length of stay (LOS) in the hospital, with an odds ratio of 2.43, suggesting that ONS alone may not effectively reduce LOS.
Factors such as comorbidity, discharge destination, and dietitian consultations also influenced LOS, indicating that a comprehensive approach is needed to improve care and reduce hospital stays for heart failure patients.
Oral nutritional supplement use in relation to length of stay in heart failure patients at a regional medical center.Babb, EB., Rohrer, J.[2022]

References

Comparing two durations of medically tailored meals posthospitalization: A randomized clinical trial. [2023]
The impact of medically tailored meals and nutrition therapy on biometric and dietary outcomes among food-insecure patients with congestive heart failure: a matched cohort study. [2022]
Oral nutritional supplement use in relation to length of stay in heart failure patients at a regional medical center. [2022]
"More2Eat" in patients at nutritional risk during hospital stay lowers the risk of three-month mortality. [2023]
The Effect of a Home Delivery Meal Service of Energy- and Protein-Rich Meals on Quality of Life in Malnourished Outpatients Suffering from Lung Cancer: A Randomized Controlled Trial. [2018]
Protocol for a randomized controlled trial of medically tailored meals compared to usual care among individuals with type 2 diabetes in Australia. [2023]
An organizational model to translate nutritional recommendations into routine clinical practice in secondary prevention of coronary artery disease. [2013]
[A novel in-hospital meal service improves protein and energy intake]. [2018]
A Review of the DASH Diet as an Optimal Dietary Plan for Symptomatic Heart Failure. [2019]
[Nutrition in Case of Heart Failure]. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Development and testing of the feasibility and acceptability of a tailored dietary intervention in patients with heart failure. [2015]
12.United Statespubmed.ncbi.nlm.nih.gov
Nutritional Interventions in Heart Failure: A Systematic Review of the Literature. [2018]